Exendin-4 improves high glucose-induced mitochondrial dysfunction of pancreatic β-cells via PKA/Drp1 signaling
Journal of Endocrinology · 2026
DOI: 10.1530/joe-26-0023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology, 2026. Verfasst von Jiahao Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University , Xuzhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Cyclic AMP-Dependent Protein Kinases, Mitochondria, Venoms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
The development of type 2 diabetes mellitus is closely associated with mitochondrial dysfunction of pancreatic β-cells, but the mechanisms by which glucagon-like peptide-1 receptor activation preserves mitochondrial homeostasis under glucotoxic conditions remain incompletely understood. Herein, we investigated whether Exendin-4 protects β-cells against chronic high glucose (HG)-induced mitochondrial injury by regulating the cAMP/PKA/Drp1 signaling pathway. INS-1 β-cells, pancreatic tissues from db/db mice, and isolated primary islets were used to assess oxidative stress, apoptosis, mitochondrial function and morphology, insulin secretion, and cAMP/PKA/Drp1 signaling. Prolonged HG exposure increased oxidative stress and apoptosis, impaired mitochondrial membrane potential, elevated mitochondrial ROS accumulation, reduced ATP content, and promoted mitochondrial fragmentation in INS-1 β-cells. These changes were accompanied by increased Drp1 expression, reduced cAMP levels and PKA activity, decreased inhibitory phosphorylation of Drp1 at Ser637, and increased Ser616 phosphorylation. Exendin-4 attenuated HG-induced oxidative stress and apoptosis, restored mitochondrial function, improved mitochondrial morphology, and partially restored Drp1 Ser637 phosphorylation, whereas it did not significantly affect HG-induced Ser616 phosphorylation. In db/db mice, Exendin-4 improved metabolic parameters and alleviated β-cell apoptosis, with partial recovery of Drp1 Ser637 phosphorylation in pancreatic islets. Furthermore, glucose-stimulated insulin secretion assays in isolated primary islets showed that Exendin-4 improved β-cell secretory function in islets isolated from db/db mice. Pharmacological inhibition of PKA with H89 attenuated Exendin-4-induced Drp1 Ser637 phosphorylation and mitochondrial protection. Collectively, these results suggest that Exendin-4 protects pancreatic β-cells against HG-induced mitochondrial dysfunction and β-cell injury by restoring PKA-associated inhibitory phosphorylation of Drp1 at Ser637 and improving mitochondrial dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University , Xuzhou, Jiangsu Province, China.
- Department of Pharmacy, Xuzhou Cancer Hospital, Affiliated Hospital of Jiangsu University , Xuzhou, Jiangsu Province, China.
- Department of Nephrology, Xuzhou New Health Hospital, Affiliated Hospital of Jiangsu University , Xuzhou, Jiangsu Province, China.
ORCID-Profile: Jiahao Zhao, Xia Zhu
Zitieren
APA
Zhao, J., Ling, X., Fan, S., Sun, Z., Huang, X., Fu, H., Liu, H., Xing, Y., & Zhu, X. (2026). Exendin-4 improves high glucose-induced mitochondrial dysfunction of pancreatic β-cells via PKA/Drp1 signaling. Journal of Endocrinology. https://doi.org/10.1530/joe-26-0023
Vancouver
Zhao J, Ling X, Fan S, Sun Z, Huang X, Fu H, et al. Exendin-4 improves high glucose-induced mitochondrial dysfunction of pancreatic β-cells via PKA/Drp1 signaling. Journal of Endocrinology. 2026. doi:10.1530/joe-26-0023
BibTeX
@article{Zhao2026,
author = {Zhao, Jiahao and Ling, Xin and Fan, Siwen and Sun, Zhenyu and Huang, Xingyu and Fu, Hao and Liu, Haiyan and Xing, Yuanyuan and Zhu, Xia},
title = {Exendin-4 improves high glucose-induced mitochondrial dysfunction of pancreatic β-cells via PKA/Drp1 signaling},
journal = {Journal of Endocrinology},
year = {2026},
doi = {10.1530/joe-26-0023}
}
EUVIMED